Latest Sirolimus Stories
A compound in the soil of Easter Island in the South Pacific significantly extends the lifespan of older mice, researchers at the University of Texas reported on Wednesday.
Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects. The class of immunosuppressive drugs known as calcineurin inhibitors
New research suggests that a common immunosuppressive drug may have the ability to boost the power of vaccines.
Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered.
People who suffer from Peutz-Jeghers syndrome, a rare inherited cancer syndrome, develop gastrointestinal polyps and are predisposed to colon cancer and other tumor types.
Rutgers researchers have discovered a potential new way to treat childhood epilepsy using a widely available therapeutic drug.
U.S. researchers have found an FDA-approved drug that might prevent genetically caused epilepsy also might help prevent more common forms of the condition. Washington University School of Medicine researchers in St.
A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
REGiMMUNE Corporation today announced that its lead product candidate RGI-2001, in combination with a low-dose of Sirolimus, demonstrated enhanced efficacy in transplantation tolerance induction in models of skin transplantation and acute Graft-versus-Host disease (GvHD).
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial.
- Emitting flashes of light; glittering.